Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Nov 25.

Published in final edited form as: Breast Cancer Res Treat. 2007 Dec 4;112(1):141–147. doi: 10.1007/s10549-007-9833-z

Table 3.

Number of tumor emboli and LYVE-1 and RhoC expression in IBC tumors from Egypt and the U.S.

	Egypt (n = 48)		U.S. (n = 12)
	No.	(%)	No.	(%)	P-value
Tumor Emboli^{(46, 12)}
Median, Min – Max	10.4, 1.0 – 62.2		3.9, 2.0 – 16.2		0.01^a
Mean ± SD	14.1 ± 14.0		5.0 ± 4.0
LYVE-1^{(45, 7)}
Positive	22	(48.9)	3	(42.9)
Negative	23	(51.1)	4	(57.1)	1.00^b
# of emboli in LYVE-1 vessels^{(22, 3)}
Median, Min – Max	2.8, 1.0 – 11.0		1.8, 1.0 – 2.0		0.15^a
Mean ± SD	3.5 ± 2.8		1.6 ± 0.5
% of emboli in LYVE-1 vessels^{(22, 3)}
Median, Min – Max	35.2, 2.5 – 100.0		27.3, 23.8 – 90.9		1.00^a
Mean ± SD	42.2 ± 33.1		47.3 ± 37.8
RhoC expression level^{(46, 7)}
Low	6	(13.0)	6	(85.7)
High	40	(87.0)	1	(14.3)	0.0003^b

^a

Mann-Whitney's U-test;

^b

Fisher's exact test